ERBB2 and breast cancer: To identify the relationship between FST expressions and clinical characteristics (pathological stage, tumor size, lymph node, distant metastasis, ER status, PR status, HER-2 status, molecular subtype, histological type and survival status) in breast carcinogenesis, the mRNA-seq data of 935 BC patients were recruited from the TCGA database.